Europe
Dr Gould brings her substantial expertise and network to the anti-infective company at a crucial time, ahead of entering the clinical stage with lead candidate NOSO-502
BioArctic AB has been awarded a grant from EU’s research and innovation program Horizon 2020.
YUPELRI (revefenacin) is the first and only once-daily, nebulized bronchodilator approved for the treatment of COPD in the US
Results to be presented at the AASLD congress 2018, 9-13 November
Medtronic plc announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com.
During the annual congress of the French Society of Pathology which is held held from 5th to 8th November 2018 in Paris, AP-HP, Greater Paris University Hospitals and TRIBVN Healthcare are pleased to announce a 5-year strategic partnership to develop and operate a National Telepathology Platform.
Promore Pharma AB today announced the composition of the Nomination Committee for the Annual General Meeting 2019, which will be held on Tuesday 21 May 2019.
50/50 joint venture with investor syndicate led by Vivo Capital
Even with the Thanksgiving week, there is interesting and exciting research being conducted and published. Here’s a look.
An ovarian cancer treatment co-developed by Germany’s Merck KGaA and Pfizer failed to meet endpoints for overall survival and progression-free survival in a Phase III trial.
PRESS RELEASES